PTC THERAPEUTICS, INC. Total Assets

Quick Answer

PTC THERAPEUTICS, INC. reported Total Assets of $2.90 billion for the year ending 2025.

  • PTC THERAPEUTICS, INC. showed an increase of +70.0% in Total Assets from 2024 to 2025.
  • This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $175.47 million | Q3 2013: $167.24 million | Q1 2014: $255.84 million | Q2 2014: $237.56 million | Q3 2014: $220.80 million | Q1 2015: $299.52 million | Q2 2015: $273.82 million | Q3 2015: $396.10 million | Q1 2016: $335.23 million | Q2 2016: $305.56 million | Q3 2016: $288.18 million | Q1 2017: $248.65 million | Q2 2017: $383.08 million | Q3 2017: $367.72 million | Q1 2018: $379.41 million | Q2 2018: $511.77 million | Q3 2018: $1.03 billion | Q1 2019: $1.28 billion | Q2 2019: $1.29 billion | Q3 2019: $1.64 billion | Q1 2020: $1.55 billion | Q2 2020: $1.48 billion | Q3 2020: $2.18 billion | Q1 2021: $2.11 billion | Q2 2021: $2.06 billion | Q3 2021: $2.01 billion | Q1 2022: $1.80 billion | Q2 2022: $1.80 billion | Q3 2022: $1.58 billion | Q1 2023: $1.61 billion | Q2 2023: $1.34 billion | Q3 2023: $1.26 billion | Q1 2024: $1.79 billion | Q2 2024: $1.92 billion | Q3 2024: $1.84 billion | Q1 2025: $2.66 billion | Q2 2025: $2.63 billion | Q3 2025: $2.64 billion.
  • Over the full 14 years of available data (2012 to 2025), PTC THERAPEUTICS, INC.'s Total Assets has grown by 22,074.8%.
  • Historical annual values: Fiscal year 2025: $2.90 billion | Fiscal year 2024: $1.71 billion | Fiscal year 2023: $1.90 billion | Fiscal year 2022: $1.71 billion | Fiscal year 2021: $1.94 billion | Fiscal year 2020: $2.21 billion | Fiscal year 2019: $1.62 billion | Fiscal year 2018: $1.12 billion | Fiscal year 2017: $391.65 million | Fiscal year 2016: $269.35 million | Fiscal year 2015: $365.28 million | Fiscal year 2014: $333.22 million | Fiscal year 2013: $151.90 million | Fiscal year 2012: $13.07 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: